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believe the decline in the phospholipid/protein ratio seen in
infants receiving bypass is indicative of lung injury. Finally,
by stating that our data support the findings of McGowan and
colleagues,3 we did not mean to imply that we found the same
alteration in surfactant composition that was shown in this
investigation. We were able to demonstrate a quantitative dif-
ference in surfactant, whereas McGowan and associates
showed a qualitative difference, albeit in a different patient
population.
David A. Paul, MD
Jay S. Greenspan, MD
Deborah A. Davis, MD
Pierantonio Russo, MD
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Complete resection: Yes or no?
To the Editor:
We read with great interest the article titled “Lobe-Specific
Extent of Systematic Lymph Node Dissection for Non–Small
Cell Lung Carcinomas According to a Retrospective Study of
Metastasis and Prognosis” by Asamura and associates (J
Thorac Cardiovasc Surg 1999;117:1102-11). The authors
mentioned that subcarinal lymphadenectomy is not always
necessary for tumors of the right upper lobe and left upper
segment. Their argument is based on the retrospective analy-
sis of their data, which consists of more than 166 cases.
However, we question whether these resections can be classi-
fied as “complete resection.”
The definition of “complete resection” in the management
of non–small cell lung cancer is not uniform in the literature.
The definition provided by Mountain1 has been widely
accepted in the Western world. In this definition, resection
can be considered complete when the highest station sam-
pled at thoracotomy is tumor free and extranodal disease is
not detected in any of the mediastinal nodes. According to
the definition provided by the National Cancer Center in
Japan,2 all the mediastinal stations where tumor can spread
should be removed. Thus more radical node dissection is
required to perform a complete resection according to the
Japanese definition.
Surgical resection can be beneficial only if the resection is
complete. A clearly defined “complete resection” is manda-
tory, not only as a selection criterion for surgery but also for
the postoperative classification of the patients. Otherwise, it
is impossible to detect the positive effect of surgery in the dif-
ferent stages of the disease. We wonder whether Asamura and
associates would consider any resection to be complete with-
out examining all mediastinal nodes.
Asamura and associates argued that subcarinal lymph node
dissection is not necessary for tumors localized to the right
upper lobe and upper division of the left upper segment
because single-station metastases to station 7 are rare. We
wonder how the authors can detect multiple-station metas-
tases, 37% (20/54) of which occur on the right and 50%
(17/34) on the left, without examining all mediastinal sta-
tions. They reported that tumor spread to station 7 was detect-
ed in 12% to 13% of their patients. We think that regardless
of multiple-station or single-station disease, this is too high a
percentage to be neglected. Thus, despite their conclusion,
their data indicate that subcarinal lymphadenectomy should
be performed, which is a relatively easy procedure during
thoracotomy.
A new definition for “complete resection” is urgently need-
ed. We agree with the authors that re-evaluation of the medi-
astinal dissection on the basis of the data collected may be
necessary, but the concept of lung resection for non–small
cell lung cancer should not be changed without the definition
of complete resection being revised. We argue that lung
resection for non–small cell lung cancer without systematic
lymph node dissection should not be performed until a new
definition is provided.
Cemal Asim Kutlu, MD, FETCS
Adnan Sayar, MD
Muzaffer Metin, MD
Yedikule Chest Surgery Center
Istanbul, Turkey
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Reply to the Editor:
We appreciate the interest expressed by Kutlu, Sayar, and
Metin in our consideration of the lobe-specific extent of sys-
tematic lymph node dissection for lung cancer.1 This has been
a point of discussion among thoracic surgeons for a couple of
decades.
Their question can be summarized as follows: Can a pul-
monary resection be regarded as a “complete resection” if
some mediastinal nodes are not examined? Indeed, we have
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shown that subcarinal dissection is not always necessary for
tumors in the right upper lobe and the left upper segment
because of very low prevalence of metastasis in subcarinal
nodes for these tumors. However, is such a resection, even if
the margin is completely free of tumor, really an “incomplete
resection”?
I would like to address 2 issues regarding their question.
First, the proper extent of lymph node dissection and the def-
inition of complete (incomplete as well) resection in lung
cancer should be discussed separately. The proper extent of
lymph node dissection should be based on the prevalence of
metastasis in each mediastinal site and the patient’s progno-
sis. Systematic lymph node dissection is intended for local
control and subsequent improvement of survival, and it
should be technically distinguished from simple lymph node
sampling. In this sense, we consider that subcarinal dissec-
tion does not contribute to better local control when the supe-
rior mediastinum is free of disease (negative), and it is a
rather time-consuming procedure in upper lobe tumors
according to lobe-specific data. We think that the information
gained from the superior mediastinal node can be a good sur-
rogate for the subcarinal node.
Second, the definition of “complete (incomplete) resec-
tion” in lung cancer has not been uniform. Indeed, many
investigators advocate that macroscopic or microscopic resid-
ual disease at the resection margin and the presence of tumor
in the highest mediastinal node sampled at thoracotomy be
considered as evidence of incomplete tumor resection.2-4
Others include perinodal extension as well.4 Since the sub-
carinal node is not the highest station in the mediastinum (it
is station 1 by Japanese definition and station 2 by United
States definition), its positivity for tumor does not affect the
judgment of “complete or incomplete resection.” Here I agree
that the definition of “complete (incomplete) resection” itself
is problematic, as pointed out by Kutlu, Sayar, and Metin.
The data from the Canadian Lung Oncology Group demon-
strated a very limited prognostic significance of these defini-
tions.5 That seems reasonable considering the tumor’s nature
of readiness to spread, such as in skip metastasis and occult
distant metastasis in lung cancer. I believe that the definition
of “complete resection” should be simply a resection without
any evidence of residual macroscopic or microscopic tumor,
regardless of nodal status.
I agree with Kutlu, Sayar, and Metin that the definition of
complete resection in lung cancer requires revision. However,
the strategy for systematic lymph node dissection should be
better local control.
Hisao Asamura, MD
Division of Thoracic Surgery
National Cancer Center Hospital Japan
1-1, Tsukiji 5-chome
Chuo-ku, Tokyo 104-0045, Japan
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Esophagectomy with gastric reconstruction for
achalasia
To the Editor:
I read with great interest the article by Banbury and associ-
ates, titled “Esophagectomy With Gastric Reconstruction for
Achalasia” (J Thorac Cardiovasc Surg 1999;117:1077-85).
In our department, we have been performing esophagecto-
my with gastric reconstruction for the treatment of mega-
esophagus due to Chagas disease since 1956. As proposed by
Câmara-Lopes and Ferreira-Santos,1 the operation was per-
formed in 2 stages, with the stomach brought up by the ret-
rosternal route. Since 1961, Ruy E. Ferreira-Santos and I
have been performing a 1-stage operation, leaving the stom-
ach in the bed of the resected esophagus.2 Because thoracot-
omy, laparotomy, and cervicotomy were required at the time,
I devised a rotary surgical table3 that permitted easy and rapid
changes in decubitus, making it possible to always operate in
the best position. Starting in 1985, whenever possible, we
began to perform the operation without thoracotomy.
Because of the denervation occurring in Chagas disease, an
association of megaesophagus with megacolon was found in
76% of cases, and this is the reason that the colon was never
used. However, the stomach can also have varied degrees of
denervation and dilatation, which worsened by surgery. This
was probably the cause of the stasis and regurgitation
observed in a few cases in our series. This complication was
so severe in 1 patient that 3 years later he regurgitated every-
thing he ate, with severe impairment of his nutritional status.
to solve this difficult problem, we successfully performed a
Roux-en-Y transdiaphragmatic gastrojejunal shunt. Perhaps
esphagectomy with gastric reconstruction should not be per-
formed in patients with a greatly dilated stomach. Like the
authors, we believe that pyloroplasty is imperative to avoid
gastric stasis and regurgitation.
There was also a frequent association of advanced chagasic
megaesophagus with carcinoma (3%), ulcers, and leukoplas-
tic lesions. These findings support the indication of
esophagectomy.4 Another frequent postoperative complica-
tion in our cases (12%), not reported by the authors, is diar-
rhea of varying intensity, which tends to disappear with time.
In some patients, diarrhea was accompanied by lower limb
edema, suggesting a state of nutritional deficiency. However,
